Description |
tissue factor pathway inhibitor |
matrix metallopeptidase 8 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Marimastat
- 1-Hydroxyamine-2-Isobutylmalonic Acid
- 2-Thiomethyl-3-Phenylpropanoic Acid
- 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid
- 2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione
- Glycinamid
- Batimastat
- N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA
- (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide
- (1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid
- (1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid
- 3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE
- BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE
- METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID
- 3-AMINO-AZACYCLOTRIDECAN-2-ONE
|
Diseases |
|
|
GWAS |
- Diffusing capacity of carbon monoxide ( 30694715)
- Heart rate ( 23583979)
- Lung adenocarcinoma ( 28604730)
- Waist-to-hip ratio adjusted for BMI (additive genetic model) ( 30778226)
|
|
Interacting Genes |
10 interacting genes:
APP
ELANE
F10
MMP1
MMP12
MMP7
MMP8
MMP9
PRSS3
THBS1
|
7 interacting genes:
ACAN
BCAN
CCL2
FBXO7
TFPI
TIMP2
UMOD
|
Entrez ID |
7035 |
4317 |
HPRD ID |
01064 |
00385 |
Ensembl ID |
ENSG00000003436
|
ENSG00000118113
|
Uniprot IDs |
P10646
|
B4E0I2
P22894
|
PDB IDs |
1ADZ
1IRH
1TFX
4BQD
4DTG
5NMV
6BX8
|
1A85
1A86
1BZS
1I73
1I76
1JAN
1JAO
1JAP
1JAQ
1JH1
1JJ9
1KBC
1MMB
1MNC
1ZP5
1ZS0
1ZVX
2OY2
2OY4
3DNG
3DPE
3DPF
3TT4
4QKZ
5H8X
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|